Drug Topics
MARCH 22, 2025
Dan Krinsky, BS, MS, RPh, FAPhA, and Stefanie Ferreri, PharmD, BCACP, FAPhA, discussed new OTC product releases, recalls, and other updates pharmacists should be aware of.
STAT
MARCH 24, 2025
23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne Wojcicki will depart, after she repeatedly tried and failed to take the storied but financially troubled DNA-testing startup private. The company will now try to sell itself through a court-supervised sale. It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Guardian - Pharmaceutical Industry
MARCH 22, 2025
Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.
PharmaVoice
MARCH 25, 2025
As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 23, 2025
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the various errors patients experience when using CGM devices.
STAT
MARCH 24, 2025
Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical researchers. As National Institutes of Health-funded physician-scientists, we collectively experienced the pitfalls of lab closures, pauses in clinical trial recruitment due to staffing issues and social distancing policies affecting in-person accrual, and redeployment away from research work to the frontlines to support clinical care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
MARCH 26, 2025
A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.
Drug Topics
MARCH 23, 2025
Jeffrey Gudin, MD, faculty in the department of anesthesiology and pain management at the University of Miami, said topical analgesics are safer alternatives to systemic medications.
STAT
MARCH 24, 2025
WASHINGTON — Five days after discovering their 16-year-old son Daniel Puerta unresponsive in bed, Jaime Puerta and his wife decided to discontinue life support as they stood beside him in the Los Angeles Children’s Hospital. Puerta kissed his son’s nose one last time. Daniel, who had no history of drug use, is one of countless stories tragically connected to the nation’s opioid crisis.
Pharma Marketing Network
MARCH 25, 2025
Automation, AI, budget cuts, and evolving digital strategies have prompted a growing question among pharmaceutical marketing teams: Is my pharma marketing job at risk? As companies adapt to more agile workflows and redefine what modern commercialization looks like, the roles of marketing professionals are being evaluated more critically than ever before.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
MARCH 25, 2025
The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.
Drug Topics
MARCH 25, 2025
Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.
STAT
MARCH 25, 2025
23andMe might have filed for bankruptcy , but the transformation it brought to health care over nearly two decades is irreversible. I’m a physician, scientist, and advocate for public health. I’ve witnessed how empowering people with knowledge about their own biology drives meaningful health decisions and actions, something millions have now experienced firsthand.
The Checkup by Singlecare
MARCH 25, 2025
Bupropion , commonly marketed under the brand names Wellbutrin SR, Wellbutrin XL, and Zyban, is an oral medication used for treating adult depression and seasonal affective disorder (SAD). SAD is a form of depression that occurs in a recurrent seasonal pattern and is more common or severe during winter. Bupropion is also approved by the Food and Drug Administration (FDA) as a medication for aiding smoking cessation.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MARCH 23, 2025
In a debate at the 2025 APhA Annual Meeting, speakers highlighted GLP-1s advantages in stroke prevention and weight loss vs SGLT2s superiority in heart failure, CV death reduction, and renal protection.
Drug Topics
MARCH 22, 2025
Ravi Patel, PharmD, MBA, MS, lead innovation advisor in the School of Pharmacy at the University of Pittsburgh, explains how artificial intelligence can be used in pharmacy.
STAT
MARCH 24, 2025
Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward. At the center of these challenges is the U.S. patent system and how it incentivizes anti-competitive behavior among the most powerful players. The argument is that patents — meant to spur innovation — are being gamed by drug manufacturers to extend monopoly profits and exclusivity, stifling competitio
OctariusRx
MARCH 24, 2025
Two of the top four CMS deficiencies in Ambulatory Surgery Centers last year were related to medication management. As we know, medication management citations fall under various sections of the CMS requirements (Conditions For Coverage). There isnt just one single section on medications in the CMS document, so knowing your way around the requirements is essential to ensure compliance with each element of safe medication management.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MARCH 24, 2025
National Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.
Drug Topics
MARCH 24, 2025
National Adverse Drug Event Awareness Day occurs annually on March 24 to raise awareness about minimizing the risk of adverse events caused by medications.
STAT
MARCH 24, 2025
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. To cope, we are quaffing cups of stimulation. Our choice today is peppermint.
The Happy PharmD
MARCH 25, 2025
Pharmacists who want to break into medical affairs often feel stuck. They know they want a change, but theyre unsure how to make the transitionespecially when they have zero industry experience. But heres the thing: you dont need to start over. You dont need another degree. And you dont need years of industry work under your belt. Vincent had the same doubts.
PharmaVoice
MARCH 24, 2025
The companies are striving to bring fresh innovations to cancer care, pain management and the weight loss space.
Drug Topics
MARCH 23, 2025
Stefanie Ferreri, PharmD, BCACP, FAPhA, discusses literature exploring OTC drugs, supplements, and devices used for non-prescription or self-care purposes.
Pharmacy Times
MARCH 22, 2025
Two pharmacists at the 2025 APhA Annual Meeting debate the role of continuous glucose monitoring (CGM) for non-insulin users, highlighting evolving guidelines, emerging clinical evidence, cost and coverage challenges, and the need for further research to justify widespread adoption.
Viseven
MARCH 25, 2025
There is one thing that can completely change how healthcare organizations approach their patients. It’s data. And one of the best ways to manage and use it for insights is business intelligence. In healthcare, business intelligence tools play a far more critical role than might initially seem. These tools often hold the key to solving challenges and addressing the situations, where timely access to data is paramount.
The Checkup by Singlecare
MARCH 25, 2025
During the COVID-19 pandemic, broad immunization was key, so the Centers for Disease Control and Prevention (CDC) provided funding for free vaccines. But since then, the COVID-19 virus has evolved and new boosters have helped prevent different variants. Yet in 2023, federal funding ceased. That means people had to rely on their insurance plan for coverage.
Drug Topics
MARCH 25, 2025
Haley Pals, PharmD, BCPP, and Thomas Franko, PharmD, discussed the best approaches in the use of buprenorphine for treating patients with SUD.
The FDA Law Blog
MARCH 23, 2025
By Deborah L. Livornese On Friday, March 21, 2025, FDA announced that it was further delaying the effective date for the ACNU final rule until May 27, 2025. We wrote about the December 26, 2024 publication of the final rule (89 FR 105288) here. Originally, the Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) final rule was to become effective January 27, 2025.
Pharmaceutical Commerce
MARCH 24, 2025
Peter Wells, CEO of TemperPack, discusses the life sciences industry's shift toward sustainable packaging, particularly in cold chain logistics, to replace outdated petroleum-based materials like expanded polystyrene (EPS). His insights cover the growing importance of sustainability as a business driver, emphasizing efficiency, waste reduction, regulatory pressures, and emerging innovations in biodegradable and recyclable packaging solutions.
Pharmacy Times
MARCH 25, 2025
Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicatedand often leaves patients footing the bill.
Drug Topics
MARCH 25, 2025
Jade Ranger, co-owner and pharmacist of the Prescription Shoppe, discusses how her pharmacy put patients first during the COVID-19 pandemic.
pharmaphorum
MARCH 24, 2025
DNA testing specialist 23andMe has filed for bankruptcy and co-founder and chief executive Anne Wojcicki has stepped down.
Expert insights. Personalized for you.
389 
Let's personalize your content